Skip to main content
. Author manuscript; available in PMC: 2023 Mar 7.
Published in final edited form as: ACS Nano. 2022 Jan 28;16(2):2494–2510. doi: 10.1021/acsnano.1c09108

Figure 6. Evaluating surface binding of nanoparticles.

Figure 6.

(a): Procedure for particle incubation with PRP; (b) Binding of nanoparticles to active platelets on cell-treated surface (normalized to particles on inactive platelets on cell-treated surfaces, 9 replicates). (c) Binding of nanoparticles to active platelets on collagen (normalized to particle binding on collagen surface without PRP, 6 replicates. For all tests, ns: p > 0.05; *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001 as determined through 2-way ANOVA with Bonferroni post-tests. Adapted from Biorender 39